Search
Displaying 31–40 of 654 for “Visions 2020”
-
Scientists Receive $25 Million to Develop a Vision-Restoring System that Connects to the Brain
Eye On the Cure Research NewsThe high-tech, vision-restoring system interfaces with the visual cortex, the back of the brain where visual input is processed to create the images we see.
-
A Change in Identity Might Someday Save Vision
Eye On the Cure Research NewsBy changing the identity of cells in the retina–namely rods–researchers may someday be able to slow or halt vision loss for those with retinitis pigmentosa (RP) and other related conditions.
-
Staying Alive: Saving Retinal Cells to Preserve Vision
Science EducationSometimes, saving vision simply comes down to keeping retinal cells alive, or at least slowing their degeneration.
-
Tiny Implantable Telescope Can Restore Some Central Vision in AMD
Eye On the Cure Research NewsKnown as the implantable miniature telescope (IMT), the device is surgically placed in the eye, where it focuses images onto the area of the patient’s retina that is still functional.
-
Press Releases
Three-day conference in San Diego will feature retinal science’s leading researchers and clinicians, and focus on the year’s top science and emerging treatments
-
The Foundation's Investments Are Filling the Pipeline for Vision-Saving Therapies
Eye On the Cure Research NewsIn addition to funding promising biotech start-ups, the Foundation Fighting Blindness has played a critical role in developing research talent.
-
Press Releases
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Press Releases
Program to have special translational research emphasis on inherited macular dystrophy.
-
Landing Page
June 17–June 18, 2022. Disney’s Coronado Springs Resort, Orlando, FL. VISIONS 2022, the national conference of the Foundation Fighting Blindness, is a one-of-a-kind event in which individuals who are visually impaired, and their families, hear about exciting advancements in blindness research.
-
Vision Improvements Reported in Choroideremia Gene Therapy Clinical Trial
Foundation NewsFive of six participants in the initial study group have sustained vision improvements in their treated eyes in dim settings.
